Huntsman Cancer Institute joins study aimed at improving leukemia screening, treatment

SALT LAKE CITY — The Huntsman Cancer Institute will be one of just a handful of health organizations to oversee an extensive clinical study aimed at better determining which new treatments work best for acute myeloid leukemia patients on a case-by-case basis.The purpose of the study is to discover how to quickly choose an individualized treatment route for a patient with that cancer based on molecular testing of their genetic traits, said Dr. Michael Deininger, a co-investigator of the tri